Phase II clinical and correlative study of carfilzomib, lenalidomide, and dexamethasone (CRd) in newly diagnosed multiple myeloma (MM) patients.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Neha Korde, Adriana Zingone, Mary Kwok, Elisabet E. Manasanch, Manisha Bhutani, Rene Costello, Mary Ann Yancey, Marcia Mulquin, Katherine R. Calvo, Irina Maric, Prashant Tembhare, Constance Yuan, Maryalice Stetler-Stevenson, Diane Carol Arthur, Peter L. Choyke, Karen A Kurdziel, Seth M. Steinberg, Mark Raffeld, Mark J. Roschewski, Ola Landgren
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596209258